T1	Disorder 122 151	Idiopathic pulmonary fibrosis
T4	Disorder 39 68	idiopathic pulmonary fibrosis
T5	Measurement 1069 1073	PaO2
T9	Disorder 371 374	IPF
T11	Disorder 562 565	IPF
T13	Disorder 1621 1653	secondary pulmonary hypertension
T23	Disorder 379 382	IPF
T30	Measurement 963 966	FVC
T31	Disorder 1533 1536	IPF
T37	Anatomical_entity 219 224	lungs
T38	Anatomical_entity 1226 1231	serum
T44	Anatomical_entity 1606 1611	serum
T45	Disorder 517 520	IPF
T52	Method_cue 731 744	meta-analysis
T54	Subject 274 282	patients
T55	Method_cue 94 107	meta-analysis
T62	Method_cue 466 479	meta-analysis
T67	Entity_Property 175 186	progressive
T77	Measurement 859 873	vital capacity
T78	Disorder 153 156	IPF
T84	Disorder 802 805	IPF
T85	Disorder 1492 1507	virus infection
T86	Disorder 1255 1287	secondary pulmonary hypertension
T87	Measurement 1430 1434	DLCO
T88	Disorder 1697 1700	IPF
T92	Disorder 1318 1321	IPF
T94	Disorder 421 424	IPF
N1	Reference T1 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N12	Reference T4 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N15	Reference T5 UMLS:C0202155	Oxygen measurement, partial pressure, arterial
N27	Reference T9 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N34	Reference T11 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N40	Reference T13 UMLS:C0264936	Secondary pulmonary hypertension
N79	Reference T23 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N99	Reference T30 UMLS:C3714541	Forced Vital Capacity
N101	Reference T31 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N122	Reference T37 UMLS:C0024109	Lung
N127	Reference T38 UMLS:C0229671	Serum
N142	Reference T44 UMLS:C0229671	Serum
N143	Reference T45 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N168	Reference T52 UMLS:C0920317	Meta Analysis (statistical procedure)
N177	Reference T54 UMLS:C0030705	Patients
N182	Reference T55 UMLS:C0920317	Meta Analysis (statistical procedure)
N200	Reference T62 UMLS:C0920317	Meta Analysis (statistical procedure)
N214	Reference T67 UMLS:C0205329	Progressive
N250	Reference T77 UMLS:C0042834	Vital capacity
N252	Reference T78 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N267	Reference T84 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N270	Reference T85 UMLS:C0042769	Virus Diseases
N273	Reference T86 UMLS:C0264936	Secondary pulmonary hypertension
N274	Reference T87 UMLS:C1516251	Carbon Monoxide Diffusing Capability Test
N277	Reference T88 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N288	Reference T92 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N296	Reference T94 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
T41	Biological_process 17 35	acute exacerbation
E5	Biological_process:T41 Theme:T4
N4	Reference E5 UMLS:C0743630	exacerbation acute
T65	Biological_process 348 367	acute exacerbations
E6	Biological_process:T65 Theme:T9
N6	Reference E6 UMLS:C0743630	exacerbation acute
T98	Biological_process 376 378	AE
E7	Biological_process:T98 Theme:T23
N9	Reference E7 UMLS:C0743630	exacerbation acute
T99	Biological_process 418 420	AE
E8	Biological_process:T99 Theme:T94
N10	Reference E8 UMLS:C0743630	exacerbation acute
T100	Biological_process 514 516	AE
E9	Biological_process:T100 Theme:T45
N13	Reference E9 UMLS:C0743630	exacerbation acute
T101	Biological_process 559 561	AE
E10	Biological_process:T101 Theme:T11
N14	Reference E10 UMLS:C0743630	exacerbation acute
T102	Biological_process 799 801	AE
E11	Biological_process:T102 Theme:T84
N16	Reference E11 UMLS:C0743630	exacerbation acute
T103	Biological_process 833 835	AE
E12	Biological_process:T103 
N19	Reference E12 UMLS:C0743630	exacerbation acute
T104	Biological_process 1315 1317	AE
E13	Biological_process:T104 Theme:T92
N20	Reference E13 UMLS:C0743630	exacerbation acute
T105	Biological_process 1530 1532	AE
E14	Biological_process:T105 Theme:T31
N22	Reference E14 UMLS:C0743630	exacerbation acute
T106	Biological_process 1694 1696	AE
E15	Biological_process:T106 Theme:T88
N23	Reference E15 UMLS:C0743630	exacerbation acute
T53	Measurement 1121 1156	alveolar-arterial oxygen difference
N2	Reference T53 UMLS:C0429685	Alveolar-arterial oxygen tension difference
T17	Measurement 1385 1428	diffusing lung capacity for carbon monoxide
N3	Reference T17 UMLS:C1516251	Carbon Monoxide Diffusing Capability Test
T27	Measurement 1158 1163	AaDO2
N25	Reference T27 UMLS:C0429685	Alveolar-arterial oxygen tension difference
T75	Disorder 163 170;187 203	chronic fibrotic disease
T21	GGPs 1232 1236	KL-6
N29	Reference T21 UMLS:C0057628	Mucin-1 protein
T69	GGPs 1612 1616	KL-6
N31	Reference T69 UMLS:C0057628	Mucin-1 protein
T56	Negative_regulation 845 855	reductions
E17	Negative_regulation:T56 Theme:T64
N36	Reference E17 UMLS:C3463820	Inhibition
T71	Measurement 940 961	forced vital capacity
N38	Reference T71 UMLS:C3714541	Forced Vital Capacity
T43	Measurement 1025 1028	TLC
N39	Reference T43 UMLS:C0040509	Total Lung Capacity
T64	Measurement 1004 1023	total lung capacity
N42	Reference T64 UMLS:C0040509	Total Lung Capacity
T16	Measurement 875 877	VC
N43	Reference T16 UMLS:C0042834	Vital capacity
T18	Biological_process 1556 1574	pulmonary function
E2	Biological_process:T18 
N32	Reference E2 UMLS:C0231921	Pulmonary function
T22	Correlation 1659 1669	associated
E1	Correlation:T22 Theme:E2 Theme2:T69 Theme3:E15
E4	Negative_regulation:T56 Theme:T77
N54	Reference E4 UMLS:C3463820	Inhibition
E16	Negative_regulation:T56 Theme:T71
N55	Reference E16 UMLS:C3463820	Inhibition
E18	Negative_regulation:T56 Theme:T5
N56	Reference E18 UMLS:C3463820	Inhibition
N52	Reference E1 UMLS:C0332281	Associated with
T42	Disorder 163 203	chronic and progressive fibrotic disease
R7	member_of Arg1:T42 Arg2:T75	
N28	Reference T75 UMLS:C0334133	Chronic fibrosis
N35	Reference T42 UMLS:C0334133	Chronic fibrosis
R8	member_of Arg1:T1 Arg2:T42	
